Replies to post #14251 on Avid Bioservices Inc (CDMO)

[volgoat]

too sweet....

[joe fabeetz]

Dios deal yields no cash for years.

"In exchange for these development efforts, Peregrine has the option to convert its development fees into either cash or equity in Dios at a preferential conversion rate after Phase I trials."

So Peregrine pours more money down another rathole for however long it takes to FINISH Phase I trials. And the MAB is still at the test-tube stage.

I don't see this deal doing anything to relieve Peregrine's cash flow problems. If anything, it aggravates them.